Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pruijt

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 17, 2009
FDG-PET has no definite role in preoperative imaging in gastric cancerA E Dassen, D J Lips, C J Hoekstra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2013
No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapyN Bernards, G J Creemers, G A P Nieuwenhuijzen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 9, 2008
Micro-metastases in stages I and II colon cancer are a predictor of the development of distant metastases and worse disease-free survivalP M van Schaik, E Hermans, J C van der Linden, et al.
Clinical Chemistry and Laboratory Medicine|November 22, 2011
Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresisRein M J Hoedemakers, Johannes F M Pruijt, Suzanne Hol, et al.
Clinical and Experimental Immunology|October 7, 2017
Truly selective primary IgM deficiency is probably very rareL M A Janssen, T Macken, M C W Creemers, et al.
International Journal of Cancer|February 26, 2016
Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancerS R Verhoeff, F N van Erning, V E P P Lemmens, et al.
Acta Oncologica (Stockholm, Sweden)|January 20, 2017
Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patientsJ J M Kwakman, A Baars, H Boot, et al.
Clinics and Research in Hepatology and Gastroenterology|June 15, 2019
Inflammatory bowel disease in Shwachman-Diamond syndrome; is there an association?Loes H C Nissen, Kyra E Stuurman, Cathelijne van der Feen, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 15, 2023
Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome: Real-world data from a multicenter cohort studyCamiel L M de Roij van Zuijdewijn, Peter E Westerweel, Martin R Schipperus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern NetherlandsL N van Steenbergen, H J T Rutten, G J Creemers, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 17, 2009
FDG-PET has no definite role in preoperative imaging in gastric cancerA E Dassen, D J Lips, C J Hoekstra, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2013
No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapyN Bernards, G J Creemers, G A P Nieuwenhuijzen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 9, 2008
Micro-metastases in stages I and II colon cancer are a predictor of the development of distant metastases and worse disease-free survivalP M van Schaik, E Hermans, J C van der Linden, et al.
Clinical Chemistry and Laboratory Medicine|November 22, 2011
Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresisRein M J Hoedemakers, Johannes F M Pruijt, Suzanne Hol, et al.
Clinical and Experimental Immunology|October 7, 2017
Truly selective primary IgM deficiency is probably very rareL M A Janssen, T Macken, M C W Creemers, et al.
International Journal of Cancer|February 26, 2016
Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancerS R Verhoeff, F N van Erning, V E P P Lemmens, et al.
Acta Oncologica (Stockholm, Sweden)|January 20, 2017
Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patientsJ J M Kwakman, A Baars, H Boot, et al.
Clinics and Research in Hepatology and Gastroenterology|June 15, 2019
Inflammatory bowel disease in Shwachman-Diamond syndrome; is there an association?Loes H C Nissen, Kyra E Stuurman, Cathelijne van der Feen, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|April 15, 2023
Prevalence and treatment of anemia and secondary iron overload in patients with a myelodysplastic syndrome: Real-world data from a multicenter cohort studyCamiel L M de Roij van Zuijdewijn, Peter E Westerweel, Martin R Schipperus, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern NetherlandsL N van Steenbergen, H J T Rutten, G J Creemers, et al.
Pageof 5